Mode
Text Size
Log in / Sign up

mAFP support associated with lower odds of mortality in isolated LM culprit lesionHeart surgery complexity predicts survival for patients in cardiogenic shock

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that mAFP support is associated with lower odds of mortality in isolated LM culprit lesions, but this is a hypothesis-generating signal.

This RCT substudy evaluated 355 patients with infarct-related cardiogenic shock and multivessel disease to assess the impact of microaxial flow pump (mAFP) support. The study compared mAFP support against standard care alone over a 180-day follow-up period.

Primary analysis showed that higher baseline SYNTAX scores were associated with higher odds of 180-day all-cause mortality (OR 3.12; 95% CI: 1.17-8.69). A positive correlation was found between baseline and residual SYNTAX scores (p<0.001). No significant interaction was observed between mAFP effect and SYNTAX measures (p for interaction=0.31).

In a specific subgroup with an isolated LM culprit lesion, mAFP support was associated with lower odds of 180-day all-cause mortality (OR 0.17; 95% CI: 0.03-0.99). No data regarding adverse events, serious adverse events, or tolerability were reported.

The finding regarding the isolated LM subgroup is a hypothesis-generating signal. Baseline and residual SYNTAX scores independently predicted 180-day mortality. The study's scope and the specific nature of the LM subgroup finding limit immediate broad clinical application.

How this fits prior evidence

How this fits prior evidence: This finding addresses a gap in the management of infarct-related cardiogenic shock by exploring the impact of mAFP support. While previous coverage has addressed surgical techniques like robotic-assisted coronary artery bypass grafting and interventional tools like cutting balloon predilatation, this study focuses on mechanical circulatory support and the influence of SYNTAX scores on outcomes. The results regarding mAFP in the isolated LM subgroup are currently limited to a hypothesis-generating signal.

When a patient experiences cardiogenic shock after a heart attack, their survival depends on many factors. A study of 355 patients with complex heart disease looked at how the severity of their condition, measured by a tool called a SYNTAX score, affected their 180-day survival rates. The researchers found that patients with a higher initial score faced much higher odds of death compared to those with lower or intermediate scores.

While the study also looked at a specific type of heart support called a microaxial flow pump, the results showed that the complexity of the heart disease was a consistent predictor of survival regardless of the pump's use. However, there was a small signal in a specific group: patients with a single blocked artery in the left main coronary artery. In that specific group, using the pump was associated with lower odds of death.

It is important to note that the finding regarding the specific pump for the small group is currently considered a hypothesis-generating signal. This means it is an early finding that needs more research to be fully understood. For now, the data clearly shows that the complexity of the original heart disease is a major factor in patient outcomes.

What this means for you:
The complexity of a patient's heart disease is a major predictor of survival after a heart attack.

Common questions

What does a SYNTAX score mean for a patient?

A SYNTAX score is a tool used to measure how complex a patient's coronary artery disease is. In this study of 355 patients, a higher baseline score meant the heart disease was more complex. Patients with these higher scores had significantly higher odds of mortality over a 180-day period.

How did the microaxial flow pump affect outcomes?

The study looked at how a microaxial flow pump (mAFP) affected survival. While the complexity of the heart disease was a main factor in survival, the use of the pump did not change how those scores affected outcomes. However, in a small group with a specific type of blockage, the pump was associated with lower odds of mortality.

Is the finding about the pump for specific heart blockages certain?

The finding that the pump helped a specific group with an isolated left main coronary artery blockage is currently considered a hypothesis-generating signal. This means the evidence is early and not yet definitive. You should speak with a doctor to understand how these findings apply to specific medical treatments.

Study Details

Study typeRct
Sample sizen = 355
EvidenceLevel 2
PublishedOct 2026
View Original Abstract ↓
BACKGROUND: The prognostic impact of multivessel coronary anatomy and complexity in infarct-related cardiogenic shock (CS) is insufficiently characterised. AIMS: We sought to investigate the prognostic value of baseline and residual SYNTAX scores and their influence on the effect of microaxial flow pump (mAFP) support in multivessel disease (MVD) and infarct-related CS. METHODS: In this secondary analysis of the DanGer Shock trial, MVD was defined as ≥1 non-culprit stenosis ≥70% or an isolated left main (LM) culprit lesion. Baseline SYNTAX scores were categorised as low (≤22), intermediate (23-32), or high (>32). Patients with an isolated LM culprit lesion were analysed separately. The primary outcome was 180-day all-cause mortality. RESULTS: Of 355 patients included in DanGer Shock, 256 patients had MVD; 211 had an available baseline SYNTAX score, with 26% of these in the low, 47% in the intermediate, and 27% in the high baseline SYNTAX groups. In all, 35 patients had an isolated LM culprit lesion. A high baseline SYNTAX score was associated with higher odds of 180-day all-cause mortality compared with low and intermediate baseline SYNTAX scores (adjusted odds ratio [OR] 3.12, 95% confidence interval [CI]: 1.17-8.69). A higher baseline SYNTAX score was associated with a higher residual SYNTAX score (p<0.001). The residual SYNTAX score independently predicted 180-day all-cause mortality. The mAFP effect was not modified by the baseline SYNTAX group (p for interaction=0.31). In patients with an isolated LM culprit lesion, mAFP use was associated with lower odds of 180-day all-cause mortality compared with standard care alone (adjusted OR 0.17, 95% CI: 0.03-0.99). CONCLUSIONS: Baseline and residual SYNTAX scores independently predicted 180-day mortality. The mAFP effect was not modified by SYNTAX measures. In the isolated left main subgroup, a hypothesis-generating signal towards a clinical benefit with mAFP use was observed.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.